Lineage Cell Therapeutics (LCTX) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.82% |
| Dec 31, 2025 | -1.59% |
| Sep 30, 2025 | 20.93% |
| Jun 30, 2025 | 20.43% |
| Mar 31, 2025 | 15.36% |
| Dec 31, 2024 | 9.39% |
| Sep 30, 2024 | 19.85% |
| Jun 30, 2024 | 17.02% |
| Mar 31, 2024 | 10.81% |
| Dec 31, 2023 | 4.71% |
| Sep 30, 2023 | -3.03% |
| Jun 30, 2023 | -29.10% |
| Mar 31, 2023 | -20.60% |
| Dec 31, 2022 | -22.27% |
| Sep 30, 2022 | -21.99% |
| Jun 30, 2022 | -58.83% |
| Mar 31, 2022 | -41.47% |
| Dec 31, 2021 | -22.67% |
| Sep 30, 2021 | -42.25% |
| Jun 30, 2021 | -40.13% |
| Mar 31, 2021 | -29.99% |
| Dec 31, 2020 | -5.26% |
| Sep 30, 2020 | -87.24% |
| Jun 30, 2020 | -20.77% |
| Mar 31, 2020 | -7.18% |
| Dec 31, 2019 | -50.53% |
| Sep 30, 2019 | -40.00% |
| Jun 30, 2019 | 1.89% |
| Mar 31, 2019 | -49.31% |
| Dec 31, 2018 | -80.17% |
| Sep 30, 2018 | -48.02% |
| Jun 30, 2018 | -52.37% |
| Mar 31, 2018 | -94.16% |
| Dec 31, 2017 | -124.74% |
| Sep 30, 2017 | -31.81% |
| Jun 30, 2017 | -43.65% |
| Mar 31, 2017 | -46.54% |
| Dec 31, 2016 | -34.49% |
| Sep 30, 2016 | -63.64% |
| Jun 30, 2016 | -201.89% |
| Mar 31, 2016 | 72.07% |
| Dec 31, 2015 | -6.74% |
| Sep 30, 2015 | 60.94% |
| Jun 30, 2015 | 133.34% |
| Mar 31, 2015 | 46.10% |
| Dec 31, 2014 | 30.03% |
| Sep 30, 2014 | 53.10% |
| Jun 30, 2014 | 42.33% |
| Mar 31, 2014 | 38.32% |
| Dec 31, 2013 | 44.15% |
| Sep 30, 2013 | 30.54% |